High Flow Nasal Cannula therapy in childhood asthma

High Flow Nasal Cannula therapy in childhood asthma - High Flow Nasal Cannula therapy in childhood asthma

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON54214

Enrollment

Registered

2021-01-14

Start date

2023-01-26

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma shortness of breath

Interventions

High Flow Nasal Cannula therapy

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: lungfunction liability >30% after bronchoprovocation test

Exclusion criteria

Exclusion criteria: unable to perform spirometry

Design outcomes

Primary

Measure	Time frame
Recovery time after bronchoprovocation test, measured using spirometry.	—

Secondary

Measure	Time frame
1. Recovery time after the bronchoprovocationtest, measured using diaphragmatic EMG 2. The relation between the pressures that the HFNC device produces to create the applied flow and the recovery of lungfunction after the brochoprovocation test 3. The relation between the shape of scaled tidal flow-volume curves and the recovery of lungfunction after the brochoprovocation test.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)